Lascurain, M. Bové
Camuñas-Palacín, A.
Thomas, N.
Breadon, C.
Gavrilidis, E.
Hudaib, A. R.
Gurvich, C.
Kulkarni, J.
Funding for this research was provided by:
Stanley Medical Research Institute (05T-742)
Article History
Received: 11 September 2018
Accepted: 11 March 2019
First Online: 21 March 2019
Compliance with ethical standards
:
: Authors M. Bové Lascurain, A. Camuñas-Palacín, N. Thomas, C. Breadon, E. Gavrilidis, A. R. Hudaib and C. Gurvich declare that he/she has no conflict of interest. Author H has received grants from the Australian National Health and Medical Research Centre, government grants and has received research grants from pharmaceutical companies plus honoraria to deliver educational sessions for medical practitioners. The data in this manuscript was collected in a trial of adjunctive oestradiol in women with schizophrenia that was funded by the Stanley Medical Research Institute, Washington, USA. The study was devised by Author H and analysed by the team of authors on this manuscript. There was no input from the funding group—the SMRI.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.